Limited benefit of biochemical response to combination therapy with interferon and ribavirin for patients with recurrent hepatitis C after living-donor liver transplantation

被引：0
|
作者：
Ueda, Yoshihide
Takada, Yasutsugu
Haga, Hironori
Nabeshima, Motoshige
Marusawa, Hiroyuki
Ito, Takashi
Egawa, Hiroto
Tanaka, Koichi
Uemoto, Shinji
Chiba, Tsutomu
机构：
来源：
GASTROENTEROLOGY | 2008年 / 134卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A762 / A762
页数：1
相关论文
共 50 条
  • [1] Limited benefit of biochemical response to combination therapy for patients with recurrent hepatitis C after living-donor liver transplantation
    Ueda, Yoshihide
    Takada, Yasutsugu
    Haga, Hironori
    Nabeshima, Motoshige
    Marusawa, Hiroyuki
    Ito, Takashi
    Egawa, Hiroto
    Tanaka, Koichi
    Uemoto, Shinji
    Chiba, Tsutomu
    [J]. TRANSPLANTATION, 2008, 85 (06) : 855 - 862
  • [2] Splenectomy and preemptive interferon therapy for hepatitis C patients after living-donor liver transplantation
    Kishi, Y
    Sugawara, Y
    Akamatsu, N
    Kaneko, J
    Tamura, S
    Kokudo, N
    Makuuchi, M
    [J]. CLINICAL TRANSPLANTATION, 2005, 19 (06) : 769 - 772
  • [3] Clinical features of biochemical cholestasis in patients with recurrent hepatitis C after living-donor liver transplantation
    Ueda, Y.
    Takada, Y.
    Marusawa, H.
    Haga, H.
    Sato, T.
    Tanaka, Y.
    Egawa, H.
    Uemoto, S.
    Chiba, T.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2010, 17 (07) : 481 - 487
  • [4] Simeprevir/Pegylated Interferon/Ribavirin Triple Therapy for Recurrent Hepatitis C After Living Donor Liver Transplantation
    Shinoda, Masahiro
    Ebinuma, Hirotoshi
    Itano, Osamu
    Obara, Hideaki
    Kitago, Minoru
    Hibi, Taizo
    Abe, Yuta
    Yagi, Hiroshi
    Matsubara, Kentaro
    Amemiya, Ryusuke
    Mizota, Takamasa
    Yamagishi, Yoshiyuki
    Kanai, Takanori
    Kitagawa, Yuko
    [J]. TRANSPLANTATION, 2016, 100 : S137 - S137
  • [5] Simeprevir/pegylated interferon/ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation
    Shinoda, Masahiro
    Ebinuma, Hirotoshi
    Itano, Osamu
    Yamagishi, Yoshiyuki
    Obara, Hideaki
    Kitago, Minoru
    Nakamoto, Nobuhiro
    Hibi, Taizo
    Yagi, Hiroshi
    Abe, Yuta
    Matsubara, Kentaro
    Chu, Po-sung
    Wakayama, Yuko
    Taniki, Nobuhito
    Yamaguchi, Akihiro
    Amemiya, Ryusuke
    Miyake, Rei
    Mizota, Takamasa
    Kanai, Takanori
    Kitagawa, Yuko
    [J]. HEPATOLOGY RESEARCH, 2016, 46 (11) : 1118 - 1128
  • [6] Individualized Extension of Pegylated Interferon Plus Ribavirin Therapy for Recurrent Hepatitis C Genotype 1b After Living-Donor Liver Transplantation
    Ueda, Yoshihide
    Takada, Yasutsugu
    Marusawa, Hiroyuki
    Egawa, Hiroto
    Uemoto, Shinji
    Chiba, Tsutomu
    [J]. TRANSPLANTATION, 2010, 90 (06) : 661 - 665
  • [7] Two patients treated with pegylated interferon/ribavirin/telaprevir triple therapy for recurrent hepatitis C after living donor liver transplantation
    Kawaoka, Tomokazu
    Takahashi, Shoichi
    Tatsukawa, Yumiko
    Hiramatsu, Akira
    Hiraga, Nobuhiko
    Miki, Daiki
    Tsuge, Masataka
    Imamura, Michio
    Kawakami, Yoshiiku
    Aikata, Hiroshi
    Ochi, Hidenori
    Ishiyama, Kouhei
    Ide, Kentaro
    Tashiro, Hirotaka
    Ohdan, Hideki
    Chayama, Kazuaki
    [J]. HEPATOLOGY RESEARCH, 2014, 44 (12) : 1259 - 1264
  • [8] Interferon/ribavirin combination therapy in patients with hepatitis C, reactivation after liver transplantation
    Zachoval, R
    Schirren, CA
    Mathias, B
    Diepolder, HM
    Gerlach, JT
    Gruener, N
    Jung, MC
    Pape, GR
    [J]. JOURNAL OF HEPATOLOGY, 2001, 34 : 34 - 34
  • [9] Impact of doble filtration plasmapheresis in combination with interferon and ribavirin for hepatitis C patients after living donor liver transplantation
    Taniguchi, M
    Furukawa, H
    Shimamura, T
    Suzuki, T
    Ohta, M
    Todo, S
    [J]. HEPATOLOGY, 2005, 42 (04) : 488A - 488A
  • [10] Response of fibrosing cholestatic recurrent hepatitis C following liver transplantation to combination interferon/ribavirin therapy
    Lilly, Les
    Deschenes, Marc
    Marotta, Paul J.
    [J]. HEPATOLOGY, 2007, 46 (04) : 479A - 480A
12345